Utility of tumour markers in the diagnosis of neoplastic pleural effusion

Clinica Chimica Acta

Volumn 265, Issue 2, 1997, Pages 193-205

  San Jose, M Esther ^a   Alvarez, David ^a   Valdes, Luis ^a   Sarandeses, Alfredo ^a   Valle, Jose Manuel ^a   Penela, Pedro ^a  

^a HOSPITAL DE CONXO   (Spain)

Author keywords

CA 125; CEA; NSE; Pleural Fluid; SCC; Tumour Markers

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; NEURON SPECIFIC ENOLASE; SQUAMOUS CELL CARCINOMA ANTIGEN; TUMOR MARKER;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NEOPLASM; PLEURA BIOPSY; PLEURA EFFUSION; PLEURA FLUID; PRIORITY JOURNAL; STATISTICS; THORACOCENTESIS; THORACOSCOPY; THORACOTOMY; TUBERCULOSIS;

ANTIGENS, NEOPLASM; CA-125 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; HUMANS; NEOPLASMS; PHOSPHOPYRUVATE HYDRATASE; PLEURAL EFFUSION, MALIGNANT; SERPINS; TUMOR MARKERS, BIOLOGICAL;

EID: 0030866713     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(97)00120-4     Document Type: Article

References (21)

1. Valdés I, Pose A, Suárez J et al. Cholesterol: a useful parameter for distinguishing between exudates and transudates. Chest 1991;99:1097-102.
2. C Kjeldsberg, J Knight, Pleural and Pericardial Fluids. In: Body Fluids, 3rd ed. ASCP, Chicago, 1993:159-222.
3. Ruibal A, Genollá J. Marcadores tumorales y derrame pleural. Med Clin (Barc) 1986;86:457-60.
4. Romero S, Izquierdo M, Mauri M et al. Utilidad diagnóstica de la determinación de la enolasa neuroespecifica en Liquido Pleural. Med Clin (Barc) 1989;93:568-71.
5. Hernández Hemández JR, Ruibal Morell A. Marcadores tumorales en el carcinoma broncopulmonar. Arch Bronoconeumol 1992;29:332-41.
6. Ferroni P, Szpak C, Greiner JW et al. CA 72.4. Radioimmunoassay in the diagnosis of malignant effusions. Comparison of various tumor markers. Int J Cancer 1990;46:445-51.
7. Gold P, Freedman SO. Demonstration of tumor-specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques. J Exp Med 1964;121:439.
8. Mesger J, Calavrezos A, Drings P et al. Value of serum and effusion fluid CEA levels for distinguishing between diffuse malignant mesothelioma and carcinomatous pleural metastases. Lung 1994;172:13-20.
9. Kato H, Torigoe T. Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma. Cancer 1977;40:1621-8.
10. Bast RC, Freeney M, Lazaru H et al. Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest 1981;68:1331.
11. Tamura S, Nishigaki T, Moriwaki Y et al. Tumor markers in pleural effusion diagnosis. Cancer 1988;61:298-302.
12. Beck JR, Schultz EK. The use of relative operating characteristic (ROC) curves in test performance evaluation. Arch Pathol Lab Med 1986;110:13-20.
13. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29-36.
14. Romero S, Hernández L, Salar et al A. Valor de la determinación del CA 15.3 en el diagnóstico de los derrames pleurales malignos. Rev Clin Esp 1992;190:339-43.
15. Wesselius LJ, Dark DS, Papasian ChJ. Airway carcinoembryonic antigen concentrations in patients with central lung cancer or chronic bronchitis. Chest 1990;98:393-7.
16. Paydaş S, Sargin Ö, Özbek S, Gürbüz E. Ferritin levels in malignant effusions: a useful marker?. Eur J Cancer 1990;26(8):919.
17. Ammon A, Eiffert H, Reil S et al. Tumor-associated antigens in effusions of malignant and benign origin. Clin Invest 1993;71:437-44.
18. Kandylis K, Vassilomanolakis M, Baziotis N et al. Diagnostic significance of the tumour markers CEA, CA 15.3 and CA 125 in malignant effusions in breast cancer. Ann Oncol 1990;1:435-8.
19. Mezger J, Lamerz R, Permanetter W. Diagnostic significance of carcinoembryonic antigen in the differential diagnosis of malignant mesothelioma. J Thorax Cardiovasc Surg 1990;100:860-6.
20. Suzuki K, Suzuki T, Akiyama J et al. Serum and pleural SCC-antigen levels in patients with pulmonary tuberculosis. Kekkaku 1993;Sep 68(9):551-7.
21. Menard O, Dousset B, Jacob C, Martinet Y. Improvement of the diagnosis of the cause of pleural effusion in patients with lung cancer by simultaneous quantification of carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) pleural levels. Eur J Cancer 1993;29A(13):1806-9.